Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary pulmonary lymphoma.

Brian B Graham1, Douglas J Mathisen, Eugene J Mark

  • 1Department of Thoracic Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA. brian.graham@uchsc.edu

The Annals of Thoracic Surgery
|September 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

Blood advances·2026
Same author

Pulmonary Immune Cell Landscape Altered by Exposure to HIV, <i>Schistosoma</i> and Their Combination.

International journal of molecular sciences·2026
Same author

Assessment of ad hoc lung cancer screening at a safety net hospital.

Journal of thoracic disease·2026
Same author

Schistosomiasis-Associated Pulmonary Arterial Hypertension in Brazil: A Call to Action for Enhanced Diagnostic Recognition-2025 Pulmonary Vascular Research Institute Infection in Pulmonary Vascular Disease Consortium Perspectives.

Pulmonary circulation·2026
Same author

Metabolic Checkpoints and Lymphoid Neogenesis in Lung Dendritic Cells: Mechanisms Guiding Tolerance and Chronic Lung Inflammation.

International journal of molecular sciences·2026
Same author

The emerging role of integrin signaling in pulmonary vascular disease.

American journal of physiology. Lung cellular and molecular physiology·2026
Same journal

Does prior percutaneous coronary revascularization negatively affect the outcomes of subsequent coronary artery bypass grafting?

The Annals of thoracic surgery·2026
Same journal

Lymph Node Dissection and Chylothorax - Balancing Oncologic Benefit Against Morbidity.

The Annals of thoracic surgery·2026
Same journal

Preserved Antegrade Pulmonary Blood Flow in Bidirectional Glenn: Outcomes and Considerations for Staged Palliation.

The Annals of thoracic surgery·2026
Same journal

Domo Arigato, Mr. Roboto.

The Annals of thoracic surgery·2026
Same journal

Impact of High SUVmax on Recurrence by Resection Strategy in Stage IA Adenocarcinoma ≤2 cm.

The Annals of thoracic surgery·2026
Same journal

Preoperative Treatment for Stage II NSCLC Requires Multidimensional Consideration.

The Annals of thoracic surgery·2026
See all related articles

Primary pulmonary lymphoma, often mucosa-associated lymphoid tissue (MALT) lymphoma, shows good outcomes with varied treatments. Recurrent disease is generally well-controlled, with bilateral disease posing a higher risk.

Area of Science:

  • Pulmonology
  • Oncology
  • Hematology

Background:

  • Primary pulmonary lymphoma is a rare condition with poorly understood clinical features, treatment strategies, and patient outcomes.
  • Limited data exists on the management and prognosis of this uncommon malignancy.

Purpose of the Study:

  • To review the clinical characteristics, treatment modalities, and outcomes of patients diagnosed with primary pulmonary lymphoma.
  • To elucidate the prognostic factors influencing disease recurrence and survival in primary pulmonary lymphoma.

Main Methods:

  • A retrospective analysis was conducted on primary pulmonary lymphoma cases diagnosed between 1990 and 2002 at a single institution.
  • Data on patient demographics, disease presentation, diagnostic methods, treatment interventions, and follow-up were collected and analyzed.

Related Experiment Videos

Main Results:

  • Eighteen patients were included, predominantly with mucosa-associated lymphoid tissue (MALT) lymphoma (14 cases).
  • Computed tomography-guided biopsy had limited diagnostic yield (2/8). Treatments varied widely, including surgery, chemotherapy, and radiotherapy.
  • The median time to disease recurrence or death was 6 years, with only one disease-related death. Bilateral disease was associated with increased recurrence or death risk (p=0.03).

Conclusions:

  • Primary pulmonary lymphoma, particularly MALT lymphoma, can be effectively managed with a range of therapeutic approaches, leading to favorable outcomes.
  • Recurrent disease in primary pulmonary lymphoma appears manageable, and overall prognosis is generally good, although bilateral involvement warrants closer monitoring.